Literature DB >> 14567088

[Community-acquired and nosocomial pneumonia].

T Welte1.   

Abstract

Mortality of pneumonia is low in the outside setting (1%) but rises up to 20% in hospital admitted patients. Early diagnosis and standardized therapy improve patient's prognosis. For community acquired pneumonia age, comorbidity and the setting of therapy (outside department, normal ward or intensive care unit) are the most important variables to choose an adequate antibiotic treatment. For nosocomial pneumonia risk stratification is according to severity of illness, length of hospital stay and antibiotic pretreatment. In the outpatient setting a 7-day monotherapy is mostly successful. In severe illness the combination of a betalactam antibiotic with a new fluorchinolon seems to be superior to an aminoglycosid therapy. Antibiotic resistance due to mistakes in antibiotic therapy is an increasing problem in the intensive care unit. Therefore, pneumonia preventive measures like influenza and pneumococcal vaccination become more important. Standardized hygienical procedures help to reduce nosocomial, mainly ventilator associated pneumonia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567088     DOI: 10.1007/s00108-003-0964-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  72 in total

Review 1.  Clinical practice. Antibiotic-associated diarrhea.

Authors:  John G Bartlett
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

Review 2.  Ventilator-associated pneumonia. European Task Force on ventilator-associated pneumonia.

Authors:  A Torres; J Carlet
Journal:  Eur Respir J       Date:  2001-05       Impact factor: 16.671

Review 3.  [Recommendations for the diagnosis, therapy and prevention of pneumonia in the immunocompromised host].

Authors:  K Dalhoff; S Ewig; G Höffken; J Lorenz; M Maass; J Niedermeyer; F Ratjen; T Welte; H Wilkens
Journal:  Pneumologie       Date:  2002-12

Review 4.  In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.

Authors:  J J Schentag; M C Birmingham; J A Paladino; J R Carr; J M Hyatt; A Forrest; G S Zimmer; M H Adelman; T J Cumbo
Journal:  Semin Respir Infect       Date:  1997-12

Review 5.  Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.

Authors:  M Whitby
Journal:  Int J Antimicrob Agents       Date:  1999-08       Impact factor: 5.283

6.  Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults.

Authors:  M A Marcos; M T Jiménez de Anta; J P de la Bellacasa; J González; E Martínez; E García; J Mensa; A de Roux; A Torres
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

7.  Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients.

Authors:  J Y Fagon; J Chastre; A J Hance; Y Domart; J L Trouillet; C Gibert
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

8.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.

Authors:  Sara E Cosgrove; George Sakoulas; Eli N Perencevich; Mitchell J Schwaber; Adolf W Karchmer; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2002-12-13       Impact factor: 9.079

9.  Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia.

Authors:  G U Meduri; G L Mauldin; R G Wunderink; K V Leeper; C B Jones; E Tolley; G Mayhall
Journal:  Chest       Date:  1994-07       Impact factor: 9.410

10.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

Authors:  J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

View more
  1 in total

1.  [Competence network "community acquired pneumonia" (CAPNETZ). A first interim report].

Authors:  T Welte; R Marre; N Suttorp
Journal:  Internist (Berl)       Date:  2004-04       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.